Influenza trial.
Recruiting
- Conditions
- RA, reuma, Rheumatoid Arthritis
- Registration Number
- NL-OMON21325
- Lead Sponsor
- Academisch Medisch Centrum, div Immunology and Rheumatology
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1. Able and willing to give written informed consent;
2. Age 18-85 years;
Exclusion Criteria
1. Therapy within the previous 60 days with:
A. Any experimental drug;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Frequency of in-vitro responding clones during follow-up of the new influenza A/H1N1 virus infection;<br /><br>2. Functional characterization of individual responding clones;<br /><br>3. Correlation of T-cell responses with antibody responses.
- Secondary Outcome Measures
Name Time Method Antibody titers of 1:40 or more on hemagglutination-inhibition (HI) assay to quantify the presence of specific antigens.